Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes
HbA1c levels and body weight decreased in patients with type 2 diabetes after initiating luseogliflozin therapy, regardless of drinking habits. However, it is desirable to limit alcohol consumption when considering its effects on liver fibrosis.
Authors
- Ito H (ORCID: https://orcid.org/0000-0002-8143-0082)
- Michiko Togane
- Suzuko Matsumoto
- Takahiro Koyanagi (ORCID: https://orcid.org/0000-0001-8669-4880)
- I Chiaki
- Shinichi Antoku
- Tomoko Yamasaki
- Shun Miura (ORCID: https://orcid.org/0000-0003-2841-286X)
- Ryota Someya
- Hideyuki Inoue
- Toshiko Mori
Institutions
- Edogawa Hospital (JP)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1111/jdi.70032
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35